People · Operator
Named in public records as an officer, director or promoter · active 2009–2022 · Biotech / Pharma, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Greenlight Biosciences Inc. | — | Biotech / Pharma | Series D+ | $179.4M | $3.9B | 2017 |
| Aquantia Corp | — | Other Technology | Series B | $174.7M | $769.0M | 2009 |
| Pivot3, Inc. | — | Other Technology | Series C | $153.2M | $2.1B | 2009 |
| Evolv Inc. | — | Other Technology | Series B | $39.0M | $456.8M | 2009 |
| Plutoshift, Inc. | — | Other Technology | Series A | $10.1M | $41.9M | 2019 |
| Lemon, Inc. | — | Other Technology | Series A | $5.0M | $138.7M | 2012 |
Eric O'Brien at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Eric O'Brien on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Brian R. Smith | 1 | 21 |
| Jeff Richards | 1 | 16 |
| DAVID WEIDEN | 1 | 13 |
| Matthew Walker | 1 | 11 |
| Barry Eggers | 1 | 9 |
| Jonathan Fleming | 1 | 9 |
| Chamath Palihapitiya | 1 | 9 |
| Michael Liang | 1 | 9 |
| David Furneaux | 1 | 8 |
| Jason Dinges | 1 | 8 |
| Rohini Chakravarthy | 1 | 7 |
| Asheem Chandna | 1 | 7 |
| Ganesh Kishore | 1 | 7 |
| Andrey Zarur | 1 | 6 |
| Amy Errett | 1 | 6 |
| Meyer Malka | 1 | 6 |
| John Vrionis | 1 | 5 |
| Laszlo Bock | 1 | 4 |
| Dmitry Akhanov | 1 | 4 |
| Neil Renninger | 1 | 4 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.